Co-Diagnostics Inc
CODX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.7M
Close$
$7.86
431.1% upside
Current Fair Value
431.1% upsideUndervalued by 431.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.70 Million |
|---|---|
| Enterprise Value | $-4,503,336.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-35.25 |
| Beta | 2.85 |
| Outstanding Shares | 2,253,474 |
Return
| Return on Equity | -302.34% |
|---|---|
| Return on Assets | -225.60% |
| Return on Invested Capital | -285.44% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | -0.22 |
| Price to Sales | - |
| Price to Book Ratio | 0.16 |
| Enterprise Value to Revenue | -6.27 |
| Enterprise Value to EBIT | 0.09 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.45 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-3.00
Average shareholder expectationRevenue Estimate
$132,576
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-3.00
Average shareholder expectationRevenue Estimate
$132,576
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 13.55% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.18%▼ 11.71% |
|---|---|
| Total Invested | $91,501▼ 90.27% |
| Investors Holding | 14▼ 18.00% |
ESG Score
No data
About Co-Diagnostics Inc
CEO: Dwight Egan